[Tanakan in the treatment of perinatal injuries of the central nervous system].

Clinical laboratory investigation of the efficiency of Tanakan (Beaufour Ipsen, France) was performed in 30 children (20 girls, 10 boys) of 2-7 months old with hypoxic-ischemic encephalopathy. Tanakan was taken per os 2 times a day (in the morning and dinner time) as a 0.25 ml of standard solution for 2 months. Other vasoactive, nootropic and antiaggregative drugs weren't used. Clinical-neurologic, neurosonographic studies, ultrasonic dopplerography of intracranial arteries were performed before and after the course of treatment. Efficiency of Tanakan was established in hypoxic-ischemic encephalopathy in children of an early age. By increasing a cerebral blood flow and decreasing intracranial pressure, the drug had positive influence on the motor functions and psychoemotional sphere, promoting a considerable decrease of vegetovisceral and vegetovascular disorders. Side-effects of Tanakan administration were not observed.